More: Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
More: Spectral AI Schedules 2024 Third Quarter Financial Results and Conference Call
View post: Arcutis to Report Third Quarter 2024 Financial Results and Participate in an Upcoming Investor Conference
Read the rest here: FDA Accepts New Drug Application and Grants Priority Review for TLX101-CDx (Pixclara®) Brain Cancer Imaging Agent
See original here: MediciNova Announces Update of Phase 2/3 Clinical Trial of MN-166 (ibudilast) in ALS patients (COMBAT-ALS) at the 2024 Annual NEALS Meeting (Northeast...
See original here: argenx to Report Third Quarter 2024 Financial Results and Business Update on October 31, 2024
Read the original here: Pharming Group reports third quarter 2024 financial results and provides business update
See the rest here: PolTREG launches Phase 2 cell therapy trial in children with presymptomatic diabetes
5 cm, or for tumors sized 2-5 cm, either Grade 2 with high genomic risk/Ki-67 ≥20% or Grade 31.]]>
View post: Rentschler Biopharma announces largest single investment at its headquarters in Germany
Recent Comments